DELGOCITINIB

269 reported adverse events

Drug classes: Janus Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking DELGOCITINIB:

# Side effect Count
0 PRODUCT USE IN UNAPPROVED INDICATION 58
1 PRURITUS 30
2 DERMATITIS ATOPIC 25
3 DRUG INEFFECTIVE 22
4 DERMATITIS 21
5 ERYTHEMA 20
6 RASH 17
7 BURNING SENSATION 13
8 DRY SKIN 13
9 ECZEMA 13
See all common reactions for DELGOCITINIB

DELGOCITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACETONAEMIC VOMITING 1 0.0556
1 CONJUNCTIVAL PAPILLAE 1 0.0500
2 ATOPIC KERATOCONJUNCTIVITIS 1 0.0286
3 BULLOUS IMPETIGO 1 0.0167
4 MEDIAN NERVE INJURY 1 0.0161
5 CEREBROVASCULAR ARTERIOVENOUS MALFORMATION 1 0.0115
6 ECZEMA HERPETICUM 4 0.0086
7 DERMATOPHYTOSIS OF NAIL 1 0.0084
8 ACQUIRED EPIDERMOLYSIS BULLOSA 1 0.0081
9 ADMINISTRATION SITE IRRITATION 1 0.0071
See all enriched reactions for DELGOCITINIB